WBP2 modulates G1/S transition in ER+ breast cancer cells and is a direct target of miR-206.

Ren, Yong-Qiang; Wang, Hui-Jun; Zhang, Yong-Qing; Liu, Yan-Bing

Ren, Yong-Qiang; Wang, Hui-Jun; Zhang, Yong-Qing; Liu, Yan-Bing.

Affiliation

Ren YQ; Clinical Laboratory, Linyi Central Hospital, Linyi, 276400, Shandong, China.
Wang HJ; Department of Breast and Thyroid Surgery, People's Hospital of Rizhao, Rizhao, 276800, Shandong, China.
Zhang YQ; Department of Breast Surgery, Weifang People's Hospital, Weifang, 261041, Shandong, China.
Liu YB; Breast Center, Shandong Cancer Hospital and Institute, Jinan, 250017, Shandong, China. yqz80@outlook.com.

Cancer Chemother Pharmacol ; 79(5): 1003-1011, 2017 May.

Article in En | MEDLINE | ID: mdl-28391353

Subject(s)

Adaptor Proteins, Signal Transducing/genetics; Breast Neoplasms/genetics; Breast Neoplasms/pathology; G1 Phase/genetics; MicroRNAs/genetics; Receptors, Estrogen/genetics; S Phase/genetics; 3' Untranslated Regions/genetics; Antineoplastic Agents, Hormonal/pharmacology; Binding Sites; Cell Cycle Proteins/genetics; Cell Line, Tumor; Cell Survival/drug effects; Drug Resistance, Neoplasm/drug effects; Drug Resistance, Neoplasm/genetics; Female; Gene Knockdown Techniques; Humans; MCF-7 Cells; Prognosis; Tamoxifen/pharmacology; Trans-Activators

Key words

Breast cancer; ER+; G1/S; MiR-206; WBP2

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Receptors, Estrogen / G1 Phase / S Phase / MicroRNAs / Adaptor Proteins, Signal Transducing Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Cancer Chemother Pharmacol Year: 2017 Type: Article Affiliation country: China

Fulltext

XML

PubMed Links

Search on Google